Secondary pharmacokinetic analysis of the 2R2 RCT (440 of 1,368 participants with TB infection): rifampicin exposure rose more than proportionally from 10 to 20 and 30 mg/kg/day; bioavailability was lower in Canada (-21.8%) and Vietnam (-12.3%) than Indonesia.
RCTn = 440
Gafar et al. Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial